Werewolf Therapeutics, Inc.HOWLNASDAQ
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank64
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Percentile
P64
Within normal range
vs 2Y Ago
0x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
PeriodValue
Q3 20250.05%
Q2 202519.97%
Q1 2025-32.95%
Q4 2024-14.36%
Q3 202412.10%
Q2 20247.32%
Q1 2024-233.63%
Q4 202336.39%
Q3 202334.00%
Q2 2023-10.34%
Q1 202316.61%
Q4 202217.98%
Q3 2022-4676.24%
Q2 202297.83%
Q1 2022-10.08%
Q4 2021-2.06%
Q3 2021-18.71%
Q2 2021-42.78%
Q1 2021-21.92%
Q4 2020-22.11%
Q3 2020-14.58%
Q2 2020-26.36%
Q1 20200.00%